Purchases and Sales Made in Q3 2024 in Brainstorm Cell Therapeutics Inc. (BCLI)
This table provides information about the institutional ownership of Brainstorm Cell Therapeutics Inc. (BCLI) during Q3 2024. The information is specifically focused on institutions that hold shares of BRAINSTORM CELL THERAPEUTICS INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 12, 2024
Q3 2024
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
199K+ 40.99% |
$43.7K - $83.4K
|
683K
$1.55M
|
|
|
Nov 14, 2024
Q3 2024
|
Xtx Topco LTD
London, X0 |
BUY
|
- |
53.1KNew |
$11.7K - $22.3K
|
53.1K
$121K
|
|
|
Nov 13, 2024
Q3 2024
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
24K+ 83.18% |
$5.27K - $10.1K
|
52.8K
$120K
|
|
|
Nov 14, 2024
Q3 2024
|
Morgan Stanley
New York, NY |
BUY
|
- |
12.5K+ 33.77% |
$2.75K - $5.24K
|
49.5K
$112K
|
|
|
Nov 14, 2024
Q3 2024
|
Jump Financial, LLC
Chicago, IL |
BUY
|
- |
11KNew |
$2.42K - $4.62K
|
11K
$25K
|
|
|
Nov 08, 2024
Q3 2024
|
Reuter James Wealth Management, LLC
Oklahoma City, OK |
BUY
|
- |
1.03KNew |
$227 - $434
|
1.03K
$2.35K
|
|
|
Nov 14, 2024
Q3 2024
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
115+ 7.71% |
$25.3 - $48.3
|
1.61K
$3.65K
|
|
|
Oct 10, 2024
Q3 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Dec 26, 2024
Q3 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-80- 31.37% |
$17.6 - $33.6
|
175
$397
|
|
|
Nov 08, 2024
Q3 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-80- 31.37% |
$17.6 - $33.6
|
175
$397
|
|
|
Nov 12, 2024
Q3 2024
|
Activest Wealth Management
|
SELL
|
- |
-2.07K- 29.24% |
$455 - $869
|
5.01K
$11.4K
|
|
|
Nov 08, 2024
Q3 2024
|
Simplex Trading, LLC
|
SELL
|
- |
-4.35K- 79.11% |
$958 - $1.83K
|
1.15K
$2.61K
|
|
|
Nov 14, 2024
Q3 2024
|
Ubs Group Ag
|
SELL
|
- |
-4.61K- 64.82% |
$1.01K - $1.94K
|
2.5K
$5.68K
|
|
|
Oct 11, 2024
Q3 2024
|
Creative Planning
Overland Park, KS |
SELL
|
- |
-7.08K- 33.83% |
$1.56K - $2.97K
|
13.8K
$31.4K
|
|
|
Oct 18, 2024
Q3 2024
|
Raymond James & Associates
St Petersburg, FL |
SELL
|
- |
-16.1K- 14.5% |
$3.55K - $6.78K
|
95.2K
$216K
|
|
|
Nov 14, 2024
Q3 2024
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-63.2K- 73.02% |
$13.9K - $26.6K
|
23.4K
$53K
|
|
|
Nov 14, 2024
Q3 2024
|
Two Sigma Securities, LLC
New York, NY |
SELL
|
- |
-82.2K- 80.6% |
$18.1K - $34.5K
|
19.8K
$44.9K
|
|
|
Nov 14, 2024
Q3 2024
|
Armistice Capital, LLC
New York, NY |
SELL
|
- |
-1.02M- 12.88% |
$224K - $428K
|
6.9M
$15.7M
|